Toxoplasmosis screening

Revision as of 16:07, 25 May 2017 by Aditya Ganti (talk | contribs)
Jump to navigation Jump to search

Toxoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxoplasmosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxoplasmosis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxoplasmosis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxoplasmosis screening

CDC on Toxoplasmosis screening

Toxoplasmosis screening in the news

Blogs on Toxoplasmosis screening

Directions to Hospitals Treating Toxoplasmosis

Risk calculators and risk factors for Toxoplasmosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Screening

  • Majority of the countries do not follow standard screening for the detection of toxoplasma infection during the antenatal period.
  • In countries such as France, Austria, Brazil standard screening is followed during the antenatal period for detecton of toxoplasmosis .[1]
  • Women are tested for antibodies aganist toxoplasma on their first antenatal visit, and if they are seropositive they are followed up periodically in every trimester to examine the trends in IgG titer levels.[2]
  • Women who seroconvert during gestation, fetal testing by amniocentesis and fetal blood sampling is recommended to identify the infection status in the fetus.


References

  1. Doğan K, Kafkaslı A, Karaman U, Atambay M, Karaoğlu L, Colak C (2012). "[The rates of seropositivity and seroconversion of toxoplasma infection in pregnant women]". Mikrobiyol Bul. 46 (2): 290–4. PMID 22639318.
  2. Berghold, Christian; Herzog, Sereina Annik; Jakse, Heidelinde; Berghold, Andrea (2016). "Prevalence and incidence of toxoplasmosis: a retrospective analysis of mother-child examinations, Styria, Austria, 1995 to 2012". Eurosurveillance. 21 (33). doi:10.2807/1560-7917.ES.2016.21.33.30317. ISSN 1025-496X.


Template:WikiDoc Sources